Hep C Elimination and Housing Insecurity, Hepatitis, Addiction, and Stigma Reduction In Medicine

Training and Support for Louisiana Physicians

Well-Ahead Louisiana has partnered with ECHO Institute® to develop a Hepatitis C Elimination/HHARM ECHO using the Project ECHO® (Extension for Community Healthcare Outcomes) model. 

Its goal is to inform healthcare providers and advanced practitioners of the current Hepatitis C (HCV) Elimination Plan coordinated by the Louisiana Department of Health (LDH). The plan involves removing treatment barriers and offering training to more primary care providers to cure HCV and create the development of best practices for destigmatizing drug use all while integrating Harm Reduction services in un-housed populations. The training is a combination of testing and treatment options used to target Louisianans with a probable or confirmed cases.

ECHO functions on a “hub and spoke” model with an interdisciplinary, team-based approach. Care providers and leadership will have access to experts in rural health care and health equity which allows care teams to engage in case-based learning and hear brief presentations. While content experts mentor and teach, participants freely share and receive knowledge and resources, fostering an “all teach, all learn” approach.

Sessions will be held at noon every second Friday of the month beginning Friday, July 12, 2024.

Sessions will be held at noon every second Friday of the month beginning Friday, July 12, 2024.


Number of People in Need of HCV Treatment by Parish

Definitions
People in Need of Treatment: People enrolled in Medicaid whose last HCV RNA lab reported to OPH was positive and who have no evidence of treatment.

Prescribers: Any healthcare provider who has written a prescription for DAAs since 7/15/2019

Download the Hepatitis C Elimination/HHARM ECHO flyer for more information.


Registration for the 2024 Hepatitis C Elimination/HHARM ECHO will open Monday, June 3, 2024


Who Can Participate

Trainings are for all prescribers (MDs, DOs, NPs, PAs) and clinical staff who would like to be a part of Louisiana’s elimination efforts and will serve as a resourceful connection to those interested in creating a “Hepatitis C Free Louisiana”.

Session Structure

Project ECHO series consists of monthly 1-hour training that consist of: introduction, announcements, didactic presentation, case presentation, discussion, and closing remarks.

CME credits

Participants will have an opportunity to receive one (1) AMA PRA approved CE credit based on professional availability at no cost. Credits are available to Well-Ahead Louisiana as a replicating partner of Project ECHO.

2024 Hep C Elimination ECHO Curriculum

Need Assistance? Connect with Us!

Name(Required)

Accreditation

In support of improving patient care, this activity has been planned and implemented by Bureau of Chronic Disease Prevention and Healthcare Access and Project ECHO. Project ECHO® is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

AMA Designation Statement: Project ECHO® designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ANCC Designation Statement: Project ECHO® designates this live activity for a maximum of 1.0 ANCC contact hour.  Nursing contact hours will be awarded for successful completion of program components based upon documented attendance and completion of evaluation.

AAPA Designation Statement—Live: Project ECHO® has been authorized by the American Academy of Physician Assistants (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credit. Physician Assistants should only claim credit commensurate with the extent of their participation.

Disclosure Statement: Project ECHO®, in compliance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, requires that anyone who is in a position to control the content of an educational activity disclose all relevant financial relationships they have had within the last 24 months with an ineligible company.

The following planners / presenters listed below have disclosed that they have a relevant financial relationship with an ineligible company: Gia Landry, MD, Speaker, Gilead Sciences. Inc./ FujiFilm

All of the relevant financial relationships listed for this/these individual(s) have been mitigated.

The following planners / presenters listed below have disclosed that they have a relevant financial relationship with an ineligible company: Consultant, Pfizer

All of the relevant financial relationships listed for this individual have been mitigated.